Literature DB >> 9038152

Tumor necrosis factor alpha enhances the expression of the interleukin (IL)-4 receptor alpha-chain on endothelial cells increasing IL-4 or IL-13-induced Stat6 activation.

S M Lugli1, N Feng, M H Heim, M Adam, B Schnyder, H Etter, M Yamage, H P Eugster, R A Lutz, G Zurawski, R Moser.   

Abstract

Functional receptors for interleukin (IL)-4 and IL-13 on endothelial cells consist of the 130-kDa IL-4 receptor alpha-chain (IL-4Ralpha) and a 65-75-kDa IL-13 binding subunit that are expressed in a ratio of about 1:3, respectively. The restricted number of IL-4Ralpha limits subunit heterodimerization and in turn receptor-mediated signaling. We report here, the effects of tumor necrosis factor alpha (TNF-alpha) on the expression of the receptor subunits for IL-4 and IL-13. By flow cytofluorometry and receptor-binding analysis of iodinated IL-4 and IL-13, stimulation with TNF-alpha-induced a 2-3-fold increase of the IL-4Ralpha expression. The up-regulation was also confirmed at the transcriptional level by reverse transcription-polymerase chain reaction. Radioligand cross-linking experiments revealed no change in the subunit composition of the TNF-alpha-induced receptor complex. Nevertheless, TNF-alpha stimulation led to increased activation of the IL-4-specific signal transducers and activators of transcription protein (Stat6) by IL-4 and IL-13. Thus, TNF-alpha corrects the subunit imbalance of the endothelial IL-4.IL-13 receptor complex thereby increasing receptor heterodimerization and in turn the signaling capability by IL-4 and IL-13.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9038152     DOI: 10.1074/jbc.272.9.5487

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Sustained elevated levels of VCAM-1 in cultured fibroblast-like synoviocytes can be achieved by TNF-alpha in combination with either IL-4 or IL-13 through increased mRNA stability.

Authors:  D Croft; P McIntyre; A Wibulswas; I Kramer
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

Review 2.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

3.  Acute inflammation primes myeloid effector cells for anti-inflammatory STAT6 signaling.

Authors:  Fredrik Wermeling; Robert M Anthony; Frank Brombacher; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

4.  Tumor necrosis factor alpha is a critical component of interleukin 13-mediated protective T helper cell type 2 responses during helminth infection.

Authors:  D Artis; N E Humphreys; A J Bancroft; N J Rothwell; C S Potten; R K Grencis
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

5.  Filifactor alocis and Tumor Necrosis Factor-Alpha Stimulate Synthesis of Visfatin by Human Macrophages.

Authors:  Andressa Vilas Boas Nogueira; Marjan Nokhbehsaim; Anna Damanaki; Sigrun Eick; Christian Kirschneck; Agnes Schröder; Jonathan Jantsch; James Deschner
Journal:  Int J Mol Sci       Date:  2021-01-27       Impact factor: 5.923

6.  Inhibition of angiogenesis by interleukin 4.

Authors:  O V Volpert; T Fong; A E Koch; J D Peterson; C Waltenbaugh; R I Tepper; N P Bouck
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.